Multimedia Capabilities
•
E-Newsletters
- E-TOCs
- Sponsored E-Newsletter
•
Custom Conference
Coverage
•
Live Events /
Advisory Boards
•
Microsite
•
Audiocast
•
Product Showcase
•
Special Features
•
Sponsored Online Poll
•
Sponsored Online
Survey
•
Supplements
- Print
- Digital Edition
•
Webcast
•
Web Advertising
- Collections
- Web site
- E-TOCs
- Digital Edition
Career Center
Contact Us
Advanced Search
My Account
|
Register
Home
Current Issue
•
Editorial
•
Upcoming Articles
Archives
•
Search Archives
•
Past Issues
•
Yearly Index
Topic Collections
Medical Education
•
Online CME
•
PTMG
Sponsored Programs
Patient Resources
Multimedia
•
Webcast
•
Audiocast
Information
About Us
- About Cutis
- Company
- Permissions
- Editorial Board
- Contact Us
Author Guidelines
- Info for Authors
- Manuscript Status
- Letters to the Editor
Advertisers' Info
- Reprints
- Advertising Info
- Media Kit
- Classified Rate Card
Subscriptions
•
New Subscription
•
Renew Subscription
•
Single Issue
•
Online Subscription
•
24hr/3day/7day Access
•
Single Article Access
•
Site License
ADVERTISEMENT
Home
Article
Email
Print
Download
+ More
Text
RSS Feed
CME
Continuing Medical Education
Biologic Therapy for Psoriasis: The T-Cell–Targeted Therapies—Efalizumab and Alefacept
Weinberg JM, Tutrone WD
Cutis
. 2003;71:41-45.
During the past several years, a new generation of therapies for psoriasis has been in development. These biologic therapies target the activity of T lymphocytes and cytokines responsible for the inflammatory nature of this disease. The first article of this 2-part update reviewed the tumor necrosis factor (TNF) inhibitors, infliximab and etanercept. In this article, we will review 2 therapies that target the T cell, efalizumab and alefacept.
[
PDF
|
Buy Article
|
Add to My Archive
]
RELATED ARTICLE(S)
Psoriasis in the Patient With Human Immunodeficiency Virus, Part 2: Review of Treatment
Psoriasis in the Patient With Human Immunodeficiency Virus, Part 1: Review of Pathogenesis
Cyclopamine: Inhibiting Hedgehog in the Treatment of Psoriasis
Biologic Therapy for Psoriasis: The Tumor Necrosis Factor Inhibitors—Infliximab and Etanercept
A Case of Bullous Pemphigoid Limited to Psoriatic Plaques
Biologic Therapy for Psoriasis: A Brief History, II
Biologic Therapy for Psoriasis: A Brief History, I
Psoriasis in Infancy: Therapy With Calcipotriene Ointment
Email
Print
Order Reprints
Share:
Already a print Subscriber?
Activate
to get full subscriber access to our Web site.
Missing and Damaged Issues
Must be claimed within 3 months of the cover date to qualify for a replacement, without charge.
FOR ALL NEW SUBSCRIPTIONS, RENEWALS, CHANGES OF ADDRESS, AND CANCELLATIONS
Subscription Customer Service
Please call 1-800-480-4851
Fax: 1-866-556-5909 or 516-908-3802
E-mail:
quadrantcut@emscirc.com
Technical Support
9 am to 5 pm EST, Mon. - Fri.
dilip.dorwani@qhc.com
FOR ALL NEW SUBSCRIPTIONS, RENEWALS, CHANGES OF ADDRESS, AND CANCELLATIONS
Please call (973)206-8018.
YOUR ACCESS TO ONLINE, FEATURING
Searching and reading archived articles from 2000 to present
Print, download, and save articles
Receive personalized e-mail alerts
Subscription to our monthly E-newsletter
YOUR ACCESS TO ONLINE ARTICLE, FEATURING
Ability to print, download, and save article
Share high-quality PDF with colleagues
Access to receive personalized e-mail alerts
Subscription to our monthly E-newsletters
BENEFITS OF SUBSCRIBING
Each year, you will receive 12 print issues of
Cutis
®
, which provides timely, unbiased, and practical information to enhance the day-to-day care of Cutis. In each issue, you will find:
Original clinical articles
Informative case reports
Expert review articles
Timely editorials and departments
Diagnostic clinical images
In addition to the regular edition,
Cutis
®
periodically publishes sponsored Supplements for the benefit of its readers
Your subscription also includes full access to online features, including:
Unlimited access to archived articles from 2000 to present
Ability to print, download, and save articles
Access to personalized e-mail alerts
Subscription to our monthly e-newsletters
BENEFITS OF SUBSCRIBING
Your subscription includes full access to
Cutis
®
online, featuring 12 online/digital issues of the print journal, which include:
Original clinical articles
Informative case reports
Expert review articles
Timely editorials and departments
Diagnostic clinical images
Your subscription also includes full access to
Cutis
®
online, including:
Unlimited access to archived articles from 2000 to present
Ability to print, download, and save articles
Access to personalized e-mail alerts
Subscription to our monthly e-newsletters
BENEFITS OF SUBSCRIBING
Ability to print, download, and save article
Ability to share high-quality PDF with colleagues
Access to receive personalized e-mail alerts
Subscription to our monthly e-newsletters
CUSTOMER SERVICE
FOR ALL NEW SUBSCRIPTIONS, RENEWALS, CHANGES OF ADDRESS, AND CANCELLATIONS
Subscription Customer Service
9 am to 5 pm EST Mon. - Fri.
Phone: 1-800-480-4851
Fax: 1-866-556-5909 or 516-908-3802
quadrantcut@emscirc.com
FOR TECHNICAL SUPPORT
9 am to 5 pm EST Mon. - Fri.
dilip.dorwani@qhc.com
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
Quick Poll
A.
B.
Submit Answer
View Results
ADVERTISEMENT
Breaking News
clientId = "FD1B4C99"; newsFeed = "P"; newsType = "24"; category = "3"; numberReturn = "4"; landingUrl = "Physician-Brief-News-Article.aspx";
More News
Most Popular
Most Viewed
Standard Management Options for Rosacea, Part 1: Overview and Broad Spectrum of Care
Current Regimens and Guideline Implications for the Treatment of Actinic Keratosis: Proceedings of a Clinical Roundtable at the 2011 Winter Clinical Dermatology Conference
Standard Management Options for Rosacea, Part 2: Options According to Subtype
Optimizing Topical Therapies for Treating Psoriasis: A Consensus Conference
The ORCA (Oracea
®
for Rosacea: A Community-Based Assessment) Trial: A Large-Scale, Phase 4 Trial in Papulopustular Rosacea
Most Archived
Most Downloaded
Most E-mailed
Most Viewed Collections
Top Search Terms
Month
Week
Week 1
Week 2
Week 3
Week 4
Week 5
FEATURED JOB from
MedOpportunities.com
Register
|
My Account
|
Home
|
Current Issue
|
Archives
|
Topic Collections
|
Medical Education
|
Sponsored Programs
|
Patient Resources
|
Multimedia
|
Information
|
Subscriptions
About Us
Terms of Use
Privacy Policy
Site Map
Customer Service
Advertise With Us
Career Center
Multimedia Capabilities
Contact Us
Frontline Medical Communications Inc. Publications
:
The American Journal of Orthopedics
|
Chronic Pain Perspectives
|
Clinician Reviews
|
Cosmetic Dermatology
Current Psychiatry
|
Cutis
|
Emergency Medicine
|
Federal Practitioner
|
The Female Patient
|
The Journal of Family Practice
Neurology Reviews
|
OBG Management
|
Physician's Travel & Meeting Guide
Frontline Medical Communications Inc. Websites
:
Metabolic and Endocrine Disease Summit
|
Current Psychiatry/ American Academy of Clinical Psychiatrists Update
Female Urology and Urogynecology Symposium
|
Pelvic Anatomy and Gynecologic Surgery Symposium
|
Emerging Techniques in Orthopedics, Sports Medicine & Arthroscopic Surgery
|
Minimally Invasive Surgery Symposium
|
Psychiatry for Primary Care Clinicians
|
Psychopharmacology Update
|
Generational Dermatology Summit